India Antidiabetics Market Top 5 Importing Countries and Market Competition (HHI) Analysis
In 2024, India continued to be a significant importer of antidiabetics, with the USA, India, Switzerland, UK, and Canada being the top exporting countries. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for 2020-2024 was negative at -1.33%. However, there was a notable surge in growth from 2023 to 2024, with a growth rate of 84.59%. This indicates a dynamic market for antidiabetics in India, presenting opportunities for further expansion and innovation in the sector.
India Antidiabetics Market Synopsis
The India antidiabetics market is expected to reach USD 10.9 billion by 2025, growing at a CAGR of 11.6%. India has the second largest population of diabetics in the world after China with around 62 million diabetics and this number is estimated to grow further due to aging population, changing lifestyle habits, dietary changes etc. This has resulted in high demand for antidiabetic drugs which are mainly prescribed for Type 2 diabetes mellitus (T2DM). The market is segmented into oral hypoglycemics, insulin products and injectables/infusion therapies.
Drivers of the Market:
Increasing prevalence of diabetes: With rising prevalence of Diabetes due to increasing obesity levels and sedentary lifestyles coupled with genetic factors & environmental pollution; there will be an increased demand for anti-diabetes drugs from all sectors of the society thereby driving growth in the market. Rising geriatric population: India?s elderly population is expected to triple by 2050 owing to improved healthcare facilities & higher life expectancy rates; thus resulting in more cases being diagnosed as Diabetic leading to an increase in demand for Anti -Diabetes Drugs . Growing awareness about diabetes management through medication : Government initiatives such as ?National Programme For Prevention And Control Of Diabetes , Cardiovascular Diseases And Stroke (NPCDCS) ? have been effective strategies that have helped create greater awareness among public regarding managing their condition through medications like Antidiabetics.
Challenges of the Market:
High cost associated with treatment regimes : The costs associated with purchasing antidiabetic medications can be prohibitively high especially for those hailing from lower ? income backgrounds ; creating a major challenge within the industry since making treatments available becomes difficult. Lack of patient adherence towards taking medicines regularly or properly : Patient noncompliance due towards taking their regular doses on time , often leads them back into hospitalization which increases expenses significantly ultimately hindering growth prospects within the industry.
Trends of the Market:
Increasing penetration of generic drug manufacturers across rural markets : This has enabled better accessibilities amongst patients belonging from lower economic strata who were earlier restricted because they could not afford expensive branded versions anymore ; thus leading rise in sales volume coming out from these emerging regions over short duration period. Recent advancements made concerning technology driven solutions such as Artificial Intelligence enabled continuous glucose monitors helping users manage their diabetic conditions better effectively.
Key Highlights of the Report:
- India Antidiabetics Market Outlook
- Market Size of India Antidiabetics Market, 2024
- Forecast of India Antidiabetics Market, 2031
- Historical Data and Forecast of India Antidiabetics Revenues & Volume for the Period 2021-2031
- India Antidiabetics Market Trend Evolution
- India Antidiabetics Market Drivers and Challenges
- India Antidiabetics Price Trends
- India Antidiabetics Porter's Five Forces
- India Antidiabetics Industry Life Cycle
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Product for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Insulin for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Drug Class for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Patient Population for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Paediatric for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Adult for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Geriatric for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Route of Administration for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Insulin syringe/ Insulin pen for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Insulin pump for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Intravenous infusion for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Oral for the Period 2021-2031
- Historical Data and Forecast of India Antidiabetics Market Revenues & Volume By Others for the Period 2021-2031
- India Antidiabetics Import Export Trade Statistics
- Market Opportunity Assessment By Product
- Market Opportunity Assessment By Patient Population
- Market Opportunity Assessment By Route of Administration
- India Antidiabetics Top Companies Market Share
- India Antidiabetics Competitive Benchmarking By Technical and Operational Parameters
- India Antidiabetics Company Profiles
- India Antidiabetics Key Strategic Recommendations
